Avanos Medical (AVNS) Gross Profit (2016 - 2024)
Historic Gross Profit for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to $92.9 million.
- Avanos Medical's Gross Profit fell 272.25% to $92.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $378.3 million, marking a year-over-year decrease of 239.94%. This contributed to the annual value of $379.7 million for FY2023, which is 367.83% down from last year.
- Per Avanos Medical's latest filing, its Gross Profit stood at $92.9 million for Q3 2024, which was down 272.25% from $95.6 million recorded in Q2 2024.
- In the past 5 years, Avanos Medical's Gross Profit ranged from a high of $106.6 million in Q1 2022 and a low of $32.3 million during Q4 2021
- Moreover, its 5-year median value for Gross Profit was $95.0 million (2023), whereas its average is $91.8 million.
- Its Gross Profit has fluctuated over the past 5 years, first plummeted by 6265.9% in 2021, then surged by 21857.59% in 2022.
- Quarter analysis of 5 years shows Avanos Medical's Gross Profit stood at $86.5 million in 2020, then plummeted by 62.66% to $32.3 million in 2021, then skyrocketed by 218.58% to $102.9 million in 2022, then dropped by 7.68% to $95.0 million in 2023, then dropped by 2.21% to $92.9 million in 2024.
- Its Gross Profit was $92.9 million in Q3 2024, compared to $95.6 million in Q2 2024 and $94.8 million in Q1 2024.